Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Controlled Trial Evaluating the Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds: A Stratified Analysis by Wound Etiology and Care Setting

NCT07223892 is registered in ClinicalTrials.gov with Bardia Anvar as lead sponsor.

NCT NCT07223892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Controlled Trial Evaluating the Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds: A Stratified Analysis by Wound Etiology and Care Setting
Lead sponsor
Bardia Anvar
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 1, 2026
Completion date
March 31, 2028
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial ulcers, burn wounds, chronic wounds, diabetic foot ulcers (dfus), pressure ulcers, surgical wounds, trauma wounds, venous leg ulcers (vlus)